Glasgow Early Treatment Arm FavIpiravir: A randomized controlled study of favipiravir as an early treatment arm in COVID-19 patients
Latest Information Update: 24 Feb 2025
At a glance
- Drugs Favipiravir (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Acronyms GETAFIX
- 01 Dec 2022 Status changed from active, no longer recruiting to completed.
- 18 Jul 2022 Planned End Date changed from 31 Mar 2023 to 30 Nov 2022.
- 11 Oct 2021 Planned End Date changed from 31 Dec 2021 to 31 Mar 2023.